# Automated Endoscopy Reprocessor Market

> Automated Endoscopy Reprocessor Market Research Report: Size, Share, Trend Analysis By Level of Automation (Fully Automated, Semi-Automated, Manually Assisted), By Capacity (Low Capacity (Up to 5 Endoscopes per Cycle), Medium Capacity (6-10 Endoscopes per Cycle), High Capacity (11 Endoscopes or More per Cycle), By Types (Standalone Reprocessors, Integrated Systems (Including Endoscope Washer-Disinfectors), By Endoscope Type (Flexible Endoscopes, Rigid Endoscopes), By Applications (Hospitals, Ambulatory Surgical Centers, Endoscopy Centers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.5%
- **2024:** $ 3.01 Billion
- **2025:** $ 3.3 Billion
- **2035:** $ 8.17 Billion
- **Key Players:** Olympus Corporation (JP), Pentax Medical (JP), Medivators Inc. (US), STERIS plc (GB), Getinge AB (SE), Advanced Sterilization Products (US), 3M Company (US), B. Braun Melsungen AG (DE)

**Report ID:** MRFR/HC/25320-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/automated-endoscopy-reprocessor-market-26985

---

## Market Summary

## **Automated Endoscopy Reprocessor Market Overview**

As per MRFR analysis, the Automated Endoscopy Reprocessor Market Size was estimated at 2.69 (USD Billion) in 2023. The Automated Endoscopy Reprocessor Market Industry is expected to grow from 3.01 (USD Billion) in 2024 to 6.80 (USD Billion) by 2032. The Market CAGR (growth rate) is expected to be around 9.50% during the forecast period (2024 - 2032).

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

## **Automated Endoscopy Reprocessor Market Drivers**

### **Increasing Prevalence of Gastrointestinal Diseases**

The increasing prevalence of gastrointestinal diseases across the globe is one of the major factors driving the Automated Endoscopy Reprocessor Market.

Gastrointestinal disorders, such as gastroesophageal reflux disease, inflammatory bowel disease, and colorectal cancer, have become common due to the growing consumption of unhealthy food, lack of exercise and aging population across the globe.

In order to cure and diagnose these ailments, a large number of endoscopic treatments need to be carried out, increasing the demand for AERs.

### **Technological Advancements and Innovation**

The Automated Endoscopy Reprocessor Market is also driven by technological advancements and innovation. Manufacturers are continuously introducing new and improved AERs with enhanced features and capabilities.

These advancements include improvements in reprocessing efficiency, reduced cycle times, and increased automation.

Additionally, the integration of advanced technologies, such as artificial intelligence (AI) and data analytics, is enhancing the accuracy and efficiency of AERs.

### **Growing Emphasis on Infection Prevention and Control**

Another driver of the Automated Endoscopy Reprocessor Market is the growing focus on infection prevention and control in healthcare facilities.

AERs are vital in this regard, as they eliminate the risk of infections caused by ineffective cleaning of endoscopes.

There are several guidelines and regulations that are supposed to be adhered to protect patients from the transmission of potentially harmful infections. The increased use of AERs is bound to ensure that these regulations are adhered to completely.

## **Automated Endoscopy Reprocessor Market Key Players and Competitive Insights**

Major players in the Automated Endoscopy Reprocessor Market are focused on expanding their product portfolio, either through internal development or acquisitions. For instance, in March 2021, Cantel Medical Corporation announced the acquisition of Nanosonics.

Similarly, in December 2020, STERIS Corporation announced the acquisition of Cantel Medical Corporation. These acquisitions have helped the companies strengthen their position in the Automated Endoscopy Reprocessor Market and offer a wider range of products to their customers.

Leading Automated Endoscopy Reprocessor Market players are also investing in research and development to introduce innovative products and technologies.

For instance, in January 2021, Getinge announced the launch of its new AER 4400 Automated Endoscope Reprocessor, which is designed to improve efficiency and reduce the risk of infection. Such developments are expected to drive the growth of the Automated Endoscopy Reprocessor Market in the coming years.

Stryker Corporation is a leading provider of medical technologies, including Automated Endoscopy Reprocessors. The company has a strong presence in the Automated Endoscopy Reprocessor Market with its AER product line.

Stryker's AERs are known for their reliability, efficiency, and user-friendliness. The company has a global sales and distribution network, which allows it to reach customers in all major markets. Stryker is committed to providing innovative products and services that help improve patient care.

The company invests heavily in research and development to ensure that its products are at the cutting edge of technology.

Medtronic is another major player in the Automated Endoscopy Reprocessor Market. The company's AERs are known for their high quality and performance. Medtronic has a strong focus on customer satisfaction and provides excellent technical support to its customers.

The company has a global sales and distribution network, which allows it to reach customers in all major markets.

Medtronic is committed to providing innovative products and services that help improve patient care. The company invests heavily in research and development to ensure that its products are at the cutting edge of technology.

### **Key Companies in the Automated Endoscopy Reprocessor Market Include**

- Wassenburg Medical
- Karl Storz
- EndoChoice
- Medtronic
- MD Endoscope Service
- [**Stryker**](https://www.stryker.com/us/en/endoscopy.html)
- Aesculap
- Ecolab
- Steris
- Cantel Medical
- Morita
- Olympus
- BeaconMedaes
- Getinge
- Hoya

## **Key Automated Endoscopy Reprocessor Market Trends Highlighted**

The Automated Endoscopy Reprocessor Market is experiencing a surge in demand, driven primarily by the increasing prevalence of endoscopic procedures and the growing emphasis on infection prevention and control in healthcare settings.

The adoption of automated reprocessing systems enhances efficiency and streamlines workflow, freeing up healthcare professionals for more patient-focused tasks.

Moreover, technological advancements, such as the integration of artificial intelligence and data analytics, are transforming reprocessing processes, leading to improved accuracy and traceability.

The expanding geriatric population and the rising incidence of chronic diseases further contribute to the growing need for endoscopy procedures, driving market growth.

Additionally, government regulations and initiatives aimed at improving patient safety and reducing healthcare-associated infections are shaping the market landscape, emphasizing the critical role of automated endoscopy reprocessors in maintaining high standards of hygiene and infection control.

## **Automated Endoscopy Reprocessor Market Segment Insights**

### **Automated Endoscopy Reprocessor Market Level of Automation Insights**

The Automated Endoscopy Reprocessor Market is segmented based on the level of automation as fully automated, semi-automated, and manually assisted.

The fully automated segment held the largest share of the market in 2023, accounting for more than 45% of the revenue generated in the Automated Endoscopy Reprocessor Market.

The prominence of this segment is primarily due to the rapid adoption of advanced technologies and the increasing need for effective and efficient solutions for reprocessing in healthcare facilities.

Nevertheless, the semi-automated segment is likely to register the fastest growth over the forecast period because it is affordable and easy to implement in the context of the existing reprocessing workflow.

Finally, the manually assisted Automated Endoscopy Reprocessor Market segment is not the primary option for healthcare facilities because it is somewhat inconvenient and less effective.

However, the lower costs associated with this segment will guarantee its relevance and potential applicability for smaller institutions that cannot afford complex reprocessing devices or may not need them as frequently as large healthcare centers.

The Automated Endoscopy Reprocessor Market is likely to grow substantially over the next decade because the prevalence of gastrointestinal diseases is on the rise, and global health expenditures are increasing, facilitating broader adoption of advanced technology products.

The growth in demand for Automated Endoscopy Reprocessing devices is driven by the increasing awareness of effective reprocessing and control of infections, as well as the need to ensure the highest level of patient safety.

In addition, the increasing number of minimally invasive endoscopic treatments will create conditions for the development of a high demand for automated endoscopy reprocessor products.

Key players in the Automated Endoscopy Reprocessor Market are Getinge, Olympus, and Medtronic.

These companies are likely to intensify their focus on the development of new and highly advanced reprocessing technologies to cater to the increasingly complex and specific needs of all healthcare facilities.

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Automated Endoscopy Reprocessor Market Capacity Insights**

The Automated Endoscopy Reprocessor Market is segmented by Capacity into Low Capacity (Up to 5 Endoscopes per Cycle), Medium Capacity (6-10 Endoscopes per Cycle), and High Capacity (11 Endoscopes or More per Cycle).

In 2023, the Medium Capacity segment held the largest market share, accounting for around 45% of the Automated Endoscopy Reprocessor Market revenue.

This is due to the increasing demand for efficient and cost-effective reprocessing solutions for endoscopes in hospitals and clinics.

The High-capacity segment is expected to witness significant growth in the coming years, owing to the rising number of surgical procedures and the growing adoption of automated reprocessing systems in large hospitals and healthcare facilities.

The Low-capacity segment is expected to hold a steady market share, catering to the needs of small clinics and ambulatory surgical centers.

### **Automated Endoscopy Reprocessor Market Type Insights**

The Automated Endoscopy Reprocessor Market is segmented by type into standalone reprocessors and integrated systems (including endoscope washer-disinfectors).

Integrated systems include endoscope washer-disinfectors, which are automated systems that clean and disinfect endoscopes, and standalone reprocessors, which are separate units that perform the same functions.

The Automated Endoscopy Reprocessor Market was valued at USD 1.47 billion in 2023 and is expected to grow to USD 2.8 billion by 2032, at a CAGR of 7.45% over the forecast period.

The growth of the market is attributed to the increasing demand for endoscopy procedures, the rising prevalence of healthcare-associated infections, and the need for efficient and effective reprocessing of endoscopes.

Standalone reprocessors are expected to hold a larger market share during the forecast period due to their lower cost and ease of use. Integrated systems are expected to grow at a higher CAGR due to their increased efficiency and ability to handle a larger volume of endoscopes.

### **Automated Endoscopy Reprocessor Market Endoscope Type Insights**

The Automated Endoscopy Reprocessor Market is segmented by Endoscope Type into Flexible Endoscopes and Rigid Endoscopes. Flexible endoscopes held the largest share of the market in 2023, and this trend is expected to continue during the forecast period.

The rising prevalence of gastrointestinal diseases, the increasing number of endoscopic procedures, and technological advancements in flexible endoscopes are driving the growth of this segment.

Rigid endoscopes, on the other hand, are expected to witness a steady growth rate during the forecast period due to their increasing use in minimally invasive surgeries and diagnostic procedures.

The Automated Endoscopy Reprocessor Market revenue for [Flexible Endoscopes](../../../reports/flexible-endoscopes-market-11685) is projected to reach USD 1.2 billion by 2024, growing at a CAGR of 7.6%, while the market for Rigid Endoscopes is expected to reach USD 0.27 billion by 2024, growing at a CAGR of 6.9%.

These segments represent a significant growth opportunity for manufacturers and suppliers in the Automated Endoscopy Reprocessor Market.

### **Automated Endoscopy Reprocessor Market Application Insights**

Hospitals, Ambulatory Surgical Centers, and Endoscopy Centers are the three primary applications for Automated Endoscopy Reprocessors globally. Hospitals dominate the market due to the high volume of endoscopic procedures performed in these settings.

This growth can be attributed to the increasing prevalence of gastrointestinal diseases, rising demand for minimally invasive procedures, and technological advancements in AERs.

Ambulatory Surgical Centers and Endoscopy Centers are also witnessing significant growth due to their convenience and cost-effectiveness compared to hospitals.

### **Automated Endoscopy Reprocessor Market Regional Insights**

The regional segmentation of the Automated Endoscopy Reprocessor Market offers insights into the market's geographic distribution and growth potential.

North America is expected to hold a significant share of the market, driven by the presence of major healthcare facilities and a high adoption rate of advanced medical technologies.

Europe is another key region, with a well-established healthcare infrastructure and a growing demand for automated endoscopy reprocessors.

The APAC region is projected to witness the fastest growth, owing to the increasing healthcare expenditure and the rising prevalence of gastrointestinal diseases.

South America and MEA are expected to contribute a smaller share to the overall market, but they are also witnessing steady growth due to the expanding healthcare sector and government initiatives to improve healthcare access.

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

### Automated Endoscopy Reprocessor Market Industry Developments

- **March 2023: PENTAX Medical awarded CE mark for AquaTYPHOON automated pre-cleaning solution** PENTAX Medical, a division of the HOYA Group, received the CE mark for its AquaTYPHOON automated pre-cleaning device, developed in collaboration with PlasmaBiotics. The device offers an automated alternative to manual pre-cleaning in endoscope reprocessing, aiming to improve hygiene and workflow in clinical practice.

## **Automated Endoscopy Reprocessor Market Segmentation Insights**

### **Automated Endoscopy Reprocessor Market Level of Automation Outlook**

- Fully Automated
- Semi-Automated
- Manually Assisted

### **Automated Endoscopy Reprocessor Market Capacity Outlook**

- Low Capacity (Up to 5 Endoscopes per Cycle)
- Medium Capacity (6-10 Endoscopes per Cycle)
- High Capacity (11 Endoscopes or More per Cycle)

### **Automated Endoscopy Reprocessor Market Type Outlook**

- Standalone Reprocessors
- Integrated Systems (Including Endoscope Washer-Disinfectors)

### **Automated Endoscopy Reprocessor Market Endoscope Type Outlook**

- Flexible Endoscopes
- Rigid Endoscopes

### **Automated Endoscopy Reprocessor Market Application Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Endoscopy Centers

**Automated Endoscopy Reprocessor Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Regulatory Compliance and Standards

The Automated Endoscopy Reprocessor Market is significantly influenced by the stringent regulatory compliance requirements imposed by health authorities. Regulatory bodies mandate rigorous standards for the cleaning, disinfection, and sterilization of endoscopic equipment to prevent healthcare-associated infections. Compliance with these regulations is not only essential for patient safety but also for healthcare facilities to maintain accreditation and avoid penalties. As a result, there is a growing emphasis on investing in automated reprocessing systems that meet these regulatory standards. The market is expected to witness a steady increase in demand for compliant automated reprocessors, as healthcare providers prioritize adherence to regulations while enhancing operational efficiency. This trend indicates a robust growth trajectory for the Automated Endoscopy Reprocessor Market in the coming years.

### Increased Demand for Infection Control

The heightened awareness surrounding infection control practices is a key driver for the Automated Endoscopy Reprocessor Market. As healthcare facilities strive to mitigate the risk of infections, the demand for effective reprocessing solutions has surged. Automated endoscopy reprocessors offer a reliable means of ensuring that endoscopic instruments are thoroughly cleaned and disinfected, thereby reducing the likelihood of cross-contamination. Market data suggests that the demand for these systems is expected to rise, particularly in outpatient surgical centers and hospitals, where the volume of endoscopic procedures is increasing. This growing focus on infection control is likely to propel the adoption of automated reprocessing technologies, further solidifying their role in the Automated Endoscopy Reprocessor Market.

### Rising Number of Endoscopic Procedures

The Automated Endoscopy Reprocessor Market is poised for growth due to the rising number of endoscopic procedures performed worldwide. As minimally invasive surgical techniques gain popularity, the demand for endoscopy services is increasing, leading to a corresponding rise in the need for efficient reprocessing solutions. According to recent estimates, the number of endoscopic procedures is projected to reach over 30 million annually by 2026. This surge necessitates the implementation of automated reprocessors to handle the increased workload while maintaining high standards of hygiene and safety. Consequently, healthcare facilities are likely to invest in advanced reprocessing technologies to accommodate this growing demand, thereby driving the expansion of the Automated Endoscopy Reprocessor Market.

### Cost Efficiency and Resource Optimization

Cost efficiency and resource optimization are becoming critical considerations for healthcare facilities, influencing the Automated Endoscopy Reprocessor Market. As hospitals and clinics face budget constraints, the need to streamline operations and reduce costs is paramount. Automated endoscopy reprocessors can significantly lower labor costs associated with manual cleaning processes and minimize the risk of reprocessing errors. By investing in these systems, healthcare providers can achieve a more efficient workflow, ultimately leading to better resource allocation. Market analysis indicates that facilities adopting automated solutions may experience a reduction in overall operational costs by up to 20%. This potential for cost savings is likely to drive the adoption of automated reprocessing technologies, further propelling the growth of the Automated Endoscopy Reprocessor Market.

### Technological Advancements in Automated Endoscopy Reprocessor Market

The Automated Endoscopy Reprocessor Market is experiencing a surge in technological advancements that enhance the efficiency and effectiveness of endoscope reprocessing. Innovations such as automated cleaning systems, advanced monitoring technologies, and integration with hospital information systems are becoming increasingly prevalent. These advancements not only streamline the reprocessing workflow but also ensure compliance with stringent infection control standards. The market is projected to grow at a compound annual growth rate of approximately 8% over the next few years, driven by the need for improved patient safety and operational efficiency. As healthcare facilities seek to minimize human error and optimize resource utilization, the adoption of these advanced technologies is likely to accelerate, thereby shaping the future landscape of the Automated Endoscopy Reprocessor Market.

## Future Outlook

The Automated Endoscopy Reprocessor Market is projected to grow at a 9.5% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare standards, and rising demand for efficient [sterilization](https://www.marketresearchfuture.com/reports/sterilization-equipment-market-6397) solutions.

**New opportunities:**

- Integration of AI for predictive maintenance in reprocessing systems. Development of portable endoscopy reprocessors for remote healthcare facilities. Expansion into emerging markets with tailored product offerings.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

## Segment Insights

### By Level of Automation: Fully Automated (Largest) vs. Semi-Automated (Fastest-Growing)

The Automated Endoscopy Reprocessor Market demonstrates a distinctly competitive landscape, particularly within the Level of Automation segment. Fully Automated systems hold the largest market share, benefiting from their efficiency, reliability, and the increasing preference of healthcare facilities for reducing human error. This increased preference is a result of the relentless pursuit of optimal patient care and streamlined operational processes. On the other hand, Semi-Automated systems are rapidly gaining traction, particularly among small to mid-sized practices due to their lower cost and flexibility. The adoption of Semi-Automated systems signifies a growing trend towards user-friendly technology that still offers advanced features while minimizing investment costs. Growth trends within this segment are largely driven by the rising need for proper sterilization and reprocessing of endoscopic instruments, ensuring compliance with safety standards in healthcare settings. In addition, technological advancements and increased awareness of infection control necessitate investments in efficient reprocessing machinery. The industry is witnessing a shift where hospitals are looking for effective yet cost-efficient solutions. As Semi-Automated systems evolve, they are expected to attract a broader user base, thus becoming the fastest-growing segment in this market as healthcare providers prioritize both quality and budget constraints.

Fully Automated (Dominant) vs. Manually Assisted (Emerging)

In the Automated Endoscopy Reprocessor Market, Fully Automated systems remain the dominant force, offering unparalleled efficiency, consistency, and reliability in instrument processing. These systems cater to the increasing demand for high-volume processing capabilities, seamlessly integrating into hospital workflows and adhering to stringent cleaning norms. Their advanced features reduce the potential for human error, thereby enhancing safety and compliance in clinical settings. In contrast, Manually Assisted systems, while emerging, are increasingly favored in specific contexts where budget constraints dictate investment decisions. These systems provide basic automation with a degree of manual intervention, appealing to facilities that require adaptable solutions. Moreover, as healthcare systems emphasize infection control and patient safety, both segments reveal unique strengths, addressing diverse market needs within the evolving landscape.

### By Capacity: High Capacity (Largest) vs. Low Capacity (Fastest-Growing)

The Automated Endoscopy Reprocessor Market showcases a dynamic distribution among its capacity segments. The High Capacity segment, designed to handle 11 or more endoscopes per cycle, holds the largest share of the market, driven by the increasing demand for efficient reprocessing solutions in hospitals and medical facilities facing a high volume of procedures. Meanwhile, the Low Capacity segment, which caters to up to 5 endoscopes per cycle, is gaining traction as it appeals to smaller clinics and outpatient facilities looking for cost-effective, space-saving solutions to meet their sterilization needs.

Low Capacity (Emerging) vs. High Capacity (Dominant)

The Low Capacity segment is emerging as a significant player in the Automated Endoscopy Reprocessor Market, particularly among smaller healthcare facilities that prioritize budget and space constraints. These systems are ideal for clinics that perform fewer procedures and require compact, efficient reprocessing capabilities. On the other hand, High Capacity systems are firmly established as the dominant solution for larger medical institutions facing a high patient throughput. They provide rapid turnaround times and versatility for various endoscopic instruments, making them essential for maintaining operational efficiency in bustling surgical environments.

### By Type: Standalone Reprocessors (Largest) vs. Integrated Systems (Fastest-Growing)

In the Automated Endoscopy Reprocessor Market, Standalone Reprocessors dominate the market landscape, capturing a significant portion of the market share. Their standalone capabilities provide healthcare facilities with the flexibility to utilize these systems independently, leading to widespread adoption. Meanwhile, Integrated Systems, which include Endoscope Washer-Disinfectors, are quickly gaining traction. The integration of multiple functions within a single system is appealing to providers seeking efficiency and convenience in operational workflows.

Standalone Reprocessors (Dominant) vs. Integrated Systems (Emerging)

Standalone Reprocessors are characterized by their dedicated functionality, ensuring precise and effective cleaning of endoscopic instruments. Their ability to function independently without integration into other systems positions them as a dominant choice in many healthcare settings. Conversely, Integrated Systems represent an emerging trend, fusing aspects of washing and disinfection into a single unit. This merging of capabilities attracts facilities looking to streamline processes, reduce space requirements, and enhance productivity. Both segments cater to the growing demand for efficient infection control in healthcare environments, highlighting diverse facility needs.

### By Endoscope Type: Flexible Endoscopes (Largest) vs. Rigid Endoscopes (Fastest-Growing)

The Automated Endoscopy Reprocessor Market showcases a diverse range of endoscope types, with flexible endoscopes holding the largest share. Their adaptability and versatility in various medical procedures make them a preferred choice among healthcare professionals. Conversely, rigid endoscopes, while currently smaller in market share, are seeing significant traction due to advancements in surgical techniques and increased use in specialized procedures.

Endoscope Type: Flexible (Dominant) vs. Rigid (Emerging)

Flexible endoscopes dominate the Automated Endoscopy Reprocessor Market due to their widely recognized benefits, including enhanced maneuverability and patient comfort during procedures. They are extensively used in a variety of diagnostic and therapeutic applications, leading to higher demand among healthcare facilities. On the other hand, rigid endoscopes are emerging as a vital alternative, particularly in surgical scenarios requiring precision and stability. Their growth is driven by technological innovations that improve visualization and procedural outcomes, positioning them as a compelling choice in specific clinical environments.

### By Application: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The Automated Endoscopy Reprocessor Market is significantly influenced by various applications, with hospitals holding the largest share. Hospitals typically require more extensive endoscopy services, leading to a higher demand for effective reprocessing solutions. In contrast, both ambulatory surgical centers and endoscopy centers are emerging as important segments due to their growing patient volume and focus on cost-effective procedures, which are gradually increasing their market presence.

Hospitals: Dominant vs. Ambulatory Surgical Centers: Emerging

Hospitals remain the dominant force within the Automated Endoscopy Reprocessor Market due to their comprehensive endoscopy service offerings. They benefit from larger budgets, extensive staffing, and a greater volume of procedures, which ensure a steady demand for advanced reprocessing technologies. On the other hand, ambulatory surgical centers represent an emerging segment, driven by the shift towards outpatient services. These centers emphasize efficiency and cost-effectiveness, adopting automated reprocessors to streamline operations while maintaining high standards of care. As healthcare models evolve, both segments will likely adapt to new technologies, impacting their market dynamics.

## Regional Market Share Analysis

### North America : Healthcare Innovation Leader

North America is the largest market for automated endoscopy reprocessors, holding approximately 45% of the global market share. The growth is driven by increasing healthcare expenditure, technological advancements, and stringent regulations regarding infection control. The demand for minimally invasive surgeries is also rising, further propelling market growth. Regulatory bodies like the FDA are actively involved in ensuring the safety and efficacy of medical devices, which supports market expansion. The United States is the leading country in this region, with a significant presence of key players such as Medivators Inc. and STERIS plc. Canada follows as the second-largest market, benefiting from a robust healthcare infrastructure and increasing awareness about infection prevention. The competitive landscape is characterized by continuous innovation and partnerships among major companies, enhancing product offerings and market reach.

### Europe : Regulatory Compliance Focus

Europe is the second-largest market for automated endoscopy reprocessors, accounting for approximately 30% of the global market share. The region's growth is fueled by rising healthcare standards, increasing surgical procedures, and a strong emphasis on infection control regulations. The European Medicines Agency (EMA) plays a crucial role in regulating medical devices, ensuring compliance with safety standards, which drives market growth. Germany and the United Kingdom are the leading countries in this market, with a high concentration of healthcare facilities and advanced medical technologies. Key players like Olympus Corporation and Getinge AB are actively expanding their product lines to meet the growing demand. The competitive landscape is marked by innovation and strategic collaborations, enhancing the availability of advanced sterilization solutions across the region.

### Asia-Pacific : Emerging Market Potential

Asia-Pacific is witnessing rapid growth in the automated endoscopy reprocessor market, holding approximately 20% of the global market share. The region's expansion is driven by increasing healthcare investments, a growing aging population, and rising awareness about hygiene and infection control. Countries like China and India are focusing on improving healthcare infrastructure, which is expected to boost demand for advanced medical devices, including endoscopy reprocessors. China is the largest market in this region, followed by Japan and India. The competitive landscape is evolving, with both local and international players striving to capture market share. Companies like Pentax Medical and 3M Company are enhancing their presence through strategic partnerships and product innovations, catering to the unique needs of the region's healthcare systems.

### Middle East and Africa : Healthcare Development Focus

The Middle East and Africa region is gradually emerging in the automated endoscopy reprocessor market, holding about 5% of the global market share. The growth is primarily driven by increasing healthcare investments, government initiatives to improve healthcare access, and rising awareness of infection control practices. Countries like the UAE and South Africa are leading the way in adopting advanced medical technologies, which is expected to enhance market growth. The competitive landscape in this region is characterized by a mix of local and international players. Key companies are focusing on expanding their operations and product offerings to meet the growing demand. The presence of major players like B. Braun Melsungen AG is notable, as they aim to leverage the region's healthcare development initiatives to enhance their market position.

## Competitive Benchmarking

The Automated Endoscopy Reprocessor Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for efficient and safe endoscopic procedures. Key players such as Olympus Corporation (Japan), STERIS plc (Great Britain), and Medivators Inc. (United States) are at the forefront, each adopting distinct strategies to enhance their market positioning. Olympus Corporation (Japan) focuses on innovation, particularly in developing advanced reprocessing technologies that ensure high levels of disinfection. Meanwhile, STERIS plc (Great Britain) emphasizes regional expansion, targeting emerging markets to broaden its customer base. Medivators Inc. (United States) appears to be concentrating on partnerships with healthcare facilities to streamline their reprocessing workflows, thereby enhancing operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological advancement and customer-centric solutions. In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The competitive structure is influenced by the collective actions of these key players, who are not only enhancing their product offerings but also optimizing their operational frameworks to respond to market demands effectively. In August 2025, Olympus Corporation (Japan) launched a new automated endoscopy reprocessor that integrates AI technology to monitor cleaning cycles in real-time. This strategic move is significant as it positions Olympus at the cutting edge of technological innovation, potentially improving patient safety and operational efficiency in healthcare settings. The incorporation of AI could also lead to better compliance with regulatory standards, thereby enhancing the company's reputation in the market. In September 2025, STERIS plc (Great Britain) announced a strategic partnership with a leading healthcare provider to implement its reprocessing solutions across multiple facilities. This collaboration is likely to enhance STERIS's market penetration and solidify its presence in the healthcare sector. By aligning with established healthcare networks, STERIS can leverage existing relationships to drive adoption of its advanced reprocessing technologies, which may lead to increased revenue streams. In July 2025, Medivators Inc. (United States) expanded its product line by introducing a new line of eco-friendly reprocessing solutions. This initiative reflects a growing trend towards sustainability in the healthcare industry. By prioritizing environmentally friendly products, Medivators not only addresses regulatory pressures but also appeals to a more environmentally conscious customer base, potentially differentiating itself from competitors. As of October 2025, the competitive trends in the Automated Endoscopy Reprocessor Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their technological capabilities and market reach. Looking ahead, it is anticipated that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, advanced technology, and reliable supply chains, thereby reshaping the market landscape.

## Recent News & Developments

- **March 2023: PENTAX Medical awarded CE mark for AquaTYPHOON automated pre-cleaning solution** PENTAX Medical, a division of the HOYA Group, received the CE mark for its AquaTYPHOON automated pre-cleaning device, developed in collaboration with PlasmaBiotics. The device offers an automated alternative to manual pre-cleaning in endoscope reprocessing, aiming to improve hygiene and workflow in clinical practice.

## Report Scope

| MARKET SIZE 2024 | 3.01(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 3.296(USD Billion) |
| MARKET SIZE 2035 | 8.17(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.5% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Olympus Corporation (JP), Pentax Medical (JP), Medivators Inc. (US), STERIS plc (GB), Getinge AB (SE), Advanced Sterilization Products (US), 3M Company (US), B. Braun Melsungen AG (DE) |
| Segments Covered | Level of Automation, Capacity, Types, Endoscope Type, Applications, Regional |
| Key Market Opportunities | Integration of advanced automation technologies enhances efficiency in the Automated Endoscopy Reprocessor Market. |
| Key Market Dynamics | Rising demand for efficient infection control drives innovation and competition in the Automated Endoscopy Reprocessor Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Automated Endoscopy Reprocessor Market by 2035?**
A: The market is projected to reach 8.17 USD Billion by 2035.

**Q: What was the market valuation of the Automated Endoscopy Reprocessor Market in 2024?**
A: The market valuation was 3.01 USD Billion in 2024.

**Q: What is the expected CAGR for the Automated Endoscopy Reprocessor Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market is 9.5% during the forecast period 2025 - 2035.

**Q: Which segment is anticipated to have the highest valuation in the Automated Endoscopy Reprocessor Market by 2035?**
A: The Integrated Systems segment is expected to reach 4.97 USD Billion by 2035.

**Q: How do the valuations of Fully Automated and Semi-Automated reprocessors compare by 2035?**
A: By 2035, Fully Automated reprocessors are projected to reach 3.2 USD Billion, while Semi-Automated reprocessors are expected to reach 2.7 USD Billion.

**Q: What is the expected market size for hospitals in the Automated Endoscopy Reprocessor Market by 2035?**
A: The market size for hospitals is projected to be 3.2 USD Billion by 2035.

**Q: Which key players are leading the Automated Endoscopy Reprocessor Market?**
A: Key players include Olympus Corporation, Pentax Medical, Medivators Inc., and STERIS plc.

**Q: What is the projected valuation for High Capacity reprocessors by 2035?**
A: High Capacity reprocessors are expected to reach 2.57 USD Billion by 2035.

**Q: What is the anticipated market size for Flexible Endoscopes by 2035?**
A: The market size for Flexible Endoscopes is projected to be 4.25 USD Billion by 2035.

**Q: How does the market for Ambulatory Surgical Centers compare to Endoscopy Centers by 2035?**
A: By 2035, Ambulatory Surgical Centers are projected to reach 2.1 USD Billion, while Endoscopy Centers are expected to reach 2.87 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/automated-endoscopy-reprocessor-market-26985*